( en | de | ru )

 

Disambiguation of "von Hahn, T"

Author of the publication

copydeleteadd this publication to your clipboard
Impact of single nucleotide polymorphisms in the essential HCV entry factor CD81 on HCV infectivity and neutralization

, , , , , and . Antiviral Res, (2014)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

T Hahn

Rebecca T Hahn

Eckhart von Hahn

Melanie Kerstin Vonau

Validierung des störungsspezifischen Interviews borderline personality disorder severity index - version IV (BPDSI-IV). TU Braunschweig, (2009)

T Attin

 

Other publications of authors with the same name

Host cell mTORC1 is required for HCV RNA replication, , , , , , , , , and 3 other author(s). Gut, 65 (12): 2017-2028 (2016)Characterization of the inhibition of hepatitis C virus entry by in vitro generated and patient derived oxidized low density lipoprotein, , , , , , , , , and 3 other author(s). Hepatology, 57 (5): 1716-1724 (2013)Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A, , , , , , , , , and . Hepatology, 50 (5): 1638-1645 (2009)Genetic and pharmacological perturbation of hepatitis-C virus entry, , , and . Curr Opin Virol, (October 2023)Filovirus antiviral activity of cationic amphiphilic drugs is associated with lipophilicity and ability to induce phospholipidosis, , , , , , , , and . Antimicrob Agents Chemother, (2020)The novel immunosuppressive protein kinase C inhibitor sotrastaurin has no pro-viral effects on the replication cycle of hepatitis B or C virus, , , , , , , , , and 2 other author(s). PLoS One, 6 (9): e24142 (September 2011)The green tea polyphenol epigallocatechin-3-gallate (EGCG) inhibits hepatitis C virus (HCV) entry., , , , , , , , , and 2 other author(s). Hepatology, 54 (6): 1947-1955 (Dezember 2011)Hepatitis D virus infection, innate immune response and antiviral treatments in stem cell-derived hepatocytes, , , , , , and . Liver Int, 43 (10): 2116-2129 (June 2023)SEC14L2, a lipid-binding protein, regulates HCV replication in culture with inter- and intra-genotype variations, , , , , , , , , and 7 other author(s). J Hepatol, 70 (4): 603-614 (November 2019)Antiretroviral drugs do not facilitate hepatitis C virus (HCV) infection in vitro, , , , , , , , and . Antiviral Res, 96 (1): 51-58 (July 2012)